Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DHODH | Q02127 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | MITF | O75030 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | NPC1 | O15118 | 4/20 | 0.41 |
| ▸ | RAB9A | P51151 | 4/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.40 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.39 |
| ▸ | CSNK2A2 | P19784 | 1/20 | 0.38 |
| ▸ | CSNK2B | P67870 | 1/20 | 0.38 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.38 |
| ▸ | CDC7 | O00311 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1415624 | 0.82 | CASP3 (0.45) | DHODHKMT2AMEN1POLBALDH1A1 | |
| SCHEMBL1415410 | 0.81 | AKR1C3 (0.45) | KMT2AMEN1ALDH1A1NPC1RAB9A | |
| SCHEMBL1415514 | 0.81 | AKR1C3 (0.46) | KMT2AMEN1POLBALDH1A1NPC1 | |
| SCHEMBL1415827 | 0.81 | AKR1C3 (0.45) | DHODHKMT2AMEN1POLBALDH1A1 | |
| SCHEMBL1415465 | 0.81 | MEN1 (0.49) | KMT2AMEN1POLBALDH1A1NPC1 | |
| SCHEMBL1416251 | 0.77 | SMN1; SMN2 (0.54) | KMT2AMEN1POLBALDH1A1NPC1 | |
| SCHEMBL7621011 | 0.73 | MAPT (0.49) | KMT2AMEN1POLBALDH1A1NPC1 | |
| SCHEMBL5460566 | 0.72 | MITF (0.69) | DHODHKMT2AMEN1POLBMITF | |
| SCHEMBL3900458 | 0.71 | CASP3 (0.52) | DHODHKMT2AMEN1ALDH1A1GAA | |
| Cyclooctane SCHEMBL8134205 | 0.70 | KMT2A (0.45) | KMT2AMEN1POLBALDH1A1NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1399742-B1 | QUINACRIDONE LABELLING REAGENTS FOR FLUORESCENCE DETECTION OF BIOLOGICAL MATERIALS | GE HEALTHCARE UK LTD (GB) | 2011-03-16 | — | — | EP | disclosed |
| US-7335771-B2 | Quinacridone derivatives as labelling reagents for fluorescence detection of biological materials | GE HEALTHCARE UK LIMITED (GB) | 2008-02-26 | — | — | US | disclosed |
| US-20040171014-A1 | Quinacridone derivatives as labelling reagents for flurescence detection of bilogical materials | TTP LABTECH LIMITED (GB) | 2004-09-02 | — | — | US | disclosed |
| EP-1399742-A2 | QUINACRIDONE LABELLING REAGENTS FOR FLUORESCENCE DETECTION OF BIOLOGICAL MATERIALS | Amersham Biosciences UK Limited (GB) | 2004-03-24 | — | — | EP | disclosed |
| WO-2002099432-A2 | QUINACRIDONE LABELLING REAGENTS FOR FLUORESCENCE DETECTION OF BIOLOGICAL MATERIALS | AMERSHAM BIOSCIENCES UK LIMITED (GB) | 2002-12-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040171014-A1 | Quinacridone derivatives as labelling reagents for flurescence detection of bilogical materials | Q6ZSR9, MPHOSPH6, NQO2 | DHODH 3549/4885KMT2A 4300/4885MEN1 4820/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.